DekaBank Deutsche Girozentrale Decreases Holdings in Monsanto Company (MON)
DekaBank Deutsche Girozentrale lowered its position in Monsanto Company (NYSE:MON) by 0.7% during the third quarter, according to its most recent filing with the SEC. The institutional investor owned 304,622 shares of the basic materials company’s stock after selling 2,122 shares during the period. DekaBank Deutsche Girozentrale owned 0.07% of Monsanto worth $36,122,000 at the end of the most recent quarter.
Other hedge funds have also recently made changes to their positions in the company. Pinnacle Financial Partners Inc. purchased a new position in Monsanto in the 2nd quarter valued at $114,000. Bruderman Asset Management LLC purchased a new position in Monsanto in the 2nd quarter valued at $116,000. Tower Research Capital LLC TRC lifted its holdings in Monsanto by 230.1% in the 2nd quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock valued at $128,000 after purchasing an additional 750 shares in the last quarter. Armbruster Capital Management Inc. lifted its holdings in Monsanto by 12.2% in the 2nd quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after purchasing an additional 125 shares in the last quarter. Finally, Enterprise Financial Services Corp raised its holdings in shares of Monsanto by 1.2% during the 2nd quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after acquiring an additional 16 shares during the period. Institutional investors own 74.50% of the company’s stock.
Several research analysts have recently commented on MON shares. Zacks Investment Research lowered Monsanto from a “buy” rating to a “hold” rating in a report on Tuesday, September 5th. BMO Capital Markets reissued a “buy” rating and set a $128.00 price objective on shares of Monsanto in a research report on Friday, September 1st. BidaskClub raised Monsanto from a “sell” rating to a “hold” rating in a research report on Saturday, August 19th. Vetr downgraded Monsanto from a “buy” rating to a “hold” rating and set a $122.35 price objective for the company. in a research report on Wednesday, August 2nd. Finally, Barclays PLC reissued an “equal weight” rating and set a $124.00 price objective (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. Monsanto currently has an average rating of “Hold” and an average target price of $124.61.
In other news, VP Nicole M. Ringenberg sold 7,890 shares of the business’s stock in a transaction dated Monday, October 16th. The stock was sold at an average price of $122.25, for a total transaction of $964,552.50. Following the completion of the transaction, the vice president now directly owns 38,600 shares of the company’s stock, valued at $4,718,850. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Pierre Courduroux sold 4,320 shares of the business’s stock in a transaction dated Thursday, October 19th. The stock was sold at an average price of $122.00, for a total value of $527,040.00. Following the transaction, the chief financial officer now directly owns 48,388 shares of the company’s stock, valued at $5,903,336. The disclosure for this sale can be found here. Over the last three months, insiders have sold 49,236 shares of company stock valued at $5,931,934. Corporate insiders own 0.79% of the company’s stock.
Monsanto Company (NYSE:MON) traded down $0.15 during midday trading on Tuesday, reaching $118.15. The company’s stock had a trading volume of 1,797,000 shares, compared to its average volume of 1,937,191. The firm has a market cap of $52,040.00, a P/E ratio of 21.39, a P/E/G ratio of 1.70 and a beta of 1.05. The company has a debt-to-equity ratio of 1.12, a quick ratio of 0.83 and a current ratio of 1.35. Monsanto Company has a 52 week low of $97.44 and a 52 week high of $122.79.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share for the quarter, beating the consensus estimate of ($0.41) by $0.61. The company had revenue of $2.69 billion during the quarter, compared to the consensus estimate of $2.51 billion. Monsanto had a return on equity of 42.40% and a net margin of 15.44%. Monsanto’s revenue was up 4.8% compared to the same quarter last year. During the same period in the previous year, the company posted $0.07 EPS. sell-side analysts anticipate that Monsanto Company will post 5.74 EPS for the current fiscal year.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto Company (NYSE:MON).
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with MarketBeat.com's FREE daily email newsletter.